Robin P Enever

Title: The Innovative Contributions of Robin P Enever

Introduction

Robin P Enever is a notable inventor based in Rouses Point, NY (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 4 patents. His work focuses on innovative formulations that enhance the delivery and efficacy of medicinal substances.

Latest Patents

Enever's latest patents include a groundbreaking rapamycin formulation for intravenous injection. This aqueous, injectable rapamycin solution comprises 0.1 to 10 percent of a concentrate solution of rapamycin in N,N-dimethylacetamide, with concentrations ranging from 0.25 mg/ml to 100 mg/ml. The formulation also includes a diluent solution consisting of 0.1 to 10 weight percent of one or more polyoxyethylene sorbitan esters, 10 to 60 weight percent of either polyethylene glycol 200 or 300, and 30 to 90 volume percent water. The concentration of rapamycin in the combined solution ranges from 0.05 mg/ml to 5.0 mg/ml. Additionally, Enever has developed formulations for hygroscopic pharmaceuticals, which involve pharmaceutical dosage forms for oral administration encapsulated in gelatin capsules. These capsules contain an admixture of at least one solid hygroscopic medicinal substance with an at least partially hydrogenated and/or solidified vegetable oil.

Career Highlights

Throughout his career, Enever has worked with prominent companies, including American Home Products Corporation. His experience in the pharmaceutical industry has allowed him to develop innovative solutions that address various medical challenges.

Collaborations

Enever has collaborated with notable individuals such as Thomas W Leonard and Karol Kay Mikula, contributing to the advancement of pharmaceutical technologies.

Conclusion

Robin P Enever's innovative work in pharmaceutical formulations has made a significant impact on the industry. His patents reflect a commitment to improving drug delivery systems and enhancing patient care.